Imaging efficacy of a targeted imaging agent for fluorescence endoscopy

A. J. Healey; R. Bendiksen; T. Attramadal; R. Bjerke; S. Waagene; A. M. Hvoslef; E. Johannesen

doi:10.1117/12.763345

22 February 2008 Imaging efficacy of a targeted imaging agent for fluorescence endoscopy

A. J. Healey, R. Bendiksen, T. Attramadal, R. Bjerke, S. Waagene, A. M. Hvoslef, E. Johannesen

Proceedings Volume 6867, Molecular Probes for Biomedical Applications II; 68670A (2008) https://doi.org/10.1117/12.763345
Event: SPIE BiOS, 2008, San Jose, California, United States

Abstract

Colorectal cancer is a major cause of cancer death. A significant unmet clinical need exists in the area of screening for earlier and more accurate diagnosis and treatment. We have identified a fluorescence imaging agent targeted to an early stage molecular marker for colorectal cancer. The agent is administered intravenously and imaged in a far red imaging channel as an adjunct to white light endoscopy. There is experimental evidence of preclinical proof of mechanism for the agent. In order to assess potential clinical efficacy, imaging was performed with a prototype fluorescence endoscope system designed to produce clinically relevant images. A clinical laparoscope system was modified for fluorescence imaging. The system was optimised for sensitivity. Images were recorded at settings matching those expected with a clinical endoscope implementation (at video frame rate operation). The animal model was comprised of a HCT-15 xenograft tumour expressing the target at concentration levels expected in early stage colorectal cancer. Tumours were grown subcutaneously. The imaging agent was administered intravenously at a dose of 50nmol/kg body weight. The animals were killed 2 hours post administration and prepared for imaging. A 3-4mm diameter, 1.6mm thick slice of viable tumour was placed over the opened colon and imaged with the laparoscope system. A receiver operator characteristic analysis was applied to imaging results. An area under the curve of 0.98 and a sensitivity of 87% [73, 96] and specificity of 100% [93, 100] were obtained.

Citation Download Citation

A. J. Healey, R. Bendiksen, T. Attramadal, R. Bjerke, S. Waagene, A. M. Hvoslef, and E. Johannesen "Imaging efficacy of a targeted imaging agent for fluorescence endoscopy", Proc. SPIE 6867, Molecular Probes for Biomedical Applications II, 68670A (22 February 2008); https://doi.org/10.1117/12.763345

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available